Regulatory Considerations for Neurodevelopmental Assessments

Time: 2:00 pm
day: Day Two


  • Reviewing regulatory guidance and good research practices to inform
    clinical outcome assessment measurement in clinical trials
  • Identifying challenges and solutions for the implementation of
    neurodevelopmental assessments to aid clinical medical product
    development trials
  • Discussing potential solutions for neurodevelopmental test score
    selection to identify outstanding methodological evidence for
    neurodevelopmental assessments in clinical trials and opportunities for
    pre-competitive collaboration